OBN (UK) Ltd

🎄 Join us for the OBN Christmas Lecture! 🎄 📅 Date: 12 December 📍 Location: Somerville College, Oxford We’re excited to welcome Professor Cathie Sudlow, Director of the Adolescent Health Study, to discuss "Improving Population Health through Large-Scale Data Science" on 12 December at Somerville College, Oxford. Learn how big data is driving new approaches in health and disease understanding. Afterwards, enjoy festive networking with life sciences colleagues over drinks and nibbles. 🔗 Book your place below – we look forward to celebrating with you! https://lnkd.in/eThEKSvA

#BioEurope Day 2 and OBN (UK) Ltd have been busy growing our network and sharing how we catalyse growth in the life sciences ecosystem. If you are attending the conference drop by stand 191 and say hello! These events really do highlight the benefits of networking to access new ideas, build professional connections and establish relationships. #thepowerofnetworking #lifesciencepartneringwithEBDgroup

📢 Join us for an exclusive, in-person opportunity to dive into the world of Drug Discovery at our ever-popular BioLearn course! 📅 Date: Wednesday, 4 December 📍 Location: The Ark, Hammersmith, London 🕛 Time: 12:00 - 17:00 Ideal for non-scientists in the life sciences sector, this course provides insights into how the drug discovery industry operates—from navigating the biopharmaceutical landscape to understanding the journey of a drug candidate from lab to market. Ed Zanders will deliver this in-depth session LIVE, offering a clear look at the industry's structure and commercial dynamics, especially valuable for those new to life sciences or working in non-research roles. 🎟️ Tickets OBN Member: £300 + VAT Non-Member: £450 + VAT 📧 For more information, contact Hannah.deacon@obn.org.uk, or click on the link to secure your spot: https://lnkd.in/eGGiqaXh

Yesterday we ventured to The Ark, London where Thermo Fisher Scientific kindly hosted OBN (UK) Ltd for one of our new BioLearn courses with Highlight People, 'Introduction to people management'. The course consisted of frameworks and tools to help understand how to best communicate with your teams and get the most out of the people you manage. There was a mixture of experience levels within the group, which led to buzzing conversation and excellent knowledge sharing within the room - A valuable day well spent! If you're interested in what BioLearn has to offer, head to our website: https://lnkd.in/eG3Hcxbq

T-Minus 4 days until BioEurope where OBN (UK) Ltd will exhibiting on stand 191. Many of our member community will be attending so drop by and see us Jane O'Driscoll Philip Simister Emma Durham Members Part 2. Labcorp Laverock Therapeutics LifeArc Lonza LoQus23 Therapeutics Ltd Medicines Discovery Catapult Merck Life Science Mironid® Limited Mishcon de Reya LLP MitoRx Therapeutics Nanomerics Ltd NANOVERY Orbit Discovery Oxford University Innovation Paras Biopharmaceuticals Finland Pathios Therapeutics Pelago Bioscience AB Pencil Biosciences Limited Pharmaron Biologics (UK) Ltd PharmEnable Therapeutics ProImmune Quotient Sciences Redx Pharma Revvity Sai Life Sciences Ltd Scancell Sitryx Sofinnova Partners Syneos Health Syngene International Limited Taylor Wessing tranScrip Upperton Pharma Solutions Venture Valuation AG WuXi AppTec WuXi Biologics #lifesciencepartneringwithEBDgroup

Sharing with our network an Autumn Budget 2024 Life Sciences Sector Commentary, by OBN Corporate Sponsor BDO

🔔 For those involved within HR leadership functions🔔 OBN C-Suite Breakfast: 'How will the latest Employment Law changes impact growing R&D companies' The new government's 'Employment Rights Bill' has been described as the biggest upgrade to workers' rights in a generation. During this discussion-based event, keynote speakers will provide an outline of the key changes and share their insight into how they will likely impact SME's in the life sciences industry. We will also provide an open forum for company leaders and those working within senior 'People & Culture' related roles to share and discuss their views. With thanks to our keynote speakers: Charissa Upton, Managing Associate at Penningtons Manches Cooper LLP & Benjamin Hunt, Counsel II at Syneos Health 📅 13 Nov, 2024, 08:30-10:30 📍 Syneos Health, Bloomsbury, London 🔗https://lnkd.in/eNq8qzAs Please note that places are limited and will be offered on an approval only basis. Complimentary tickets available for C-Level or equivalent OBN Members & Academic Entrepreneurs, non-OBN Member tickets are available for £50.00 plus VAT. All tickets include breakfast. #CSuite #LifeSciences #EmploymentRightsBill

OBN (UK) Ltd are looking forward to exhibiting at BIO Europe in Stockholm next week; many of our member community will be attending, so do pop by and say hello to Jane O'Driscoll Philip Simister Emma Durham on stand 191 - we’d be delighted to see you! Members Part 1. Agility Life Sciences Ardena Axxam Barinthus Biotherapeutics Batavia Biosciences Bayer UK BDO BioAscent BioPartner UK Biopharma Group BIOPHARMA STABILITY TESTING LABORATORY LIMITED Biotechgate bit.bio Blue Matter Cancer Research UK (CRUK) Charles River Laboratories Coding Bio DLRC Regulatory Consultancy EBD Group Eli Lilly and Company Etcembly Ltd Evariste Evonik Evotec Exscientia FAREVA GenScript GTP Bioways HistologiX IDDI - Regulatory Statistics & Clinical Data Science Experts Invizius Ipsen Johnson & Johnson Kurma Partners #lifesciencepartneringwithEBDgroup

🌟 A huge thank you to everyone who joined us for our BioTuesday: Digital Transformation in MedTech! 🌟 We were thrilled to welcome so many industry leaders and innovators to EY’s ‘More London’ offices in London Bridge. A special thank you to our fantastic keynote speakers: 🔹 Alex Hay, Partner – Life Sciences, for sharing insights on Emerging Go-to-Market Models with the Rise of Digital 🔹 Seshadri (Sesh) Thirumalai, Director at EY-Parthenon, for a deep dive into Digital Transformation & Data-Driven Decision Making 🔹Nadja Ulrich on the challenges and opportunities for creating and realising value. Also, a big shout-out to the Digital MedTech R&D companies who presented their groundbreaking work: Francesca Cordeiro from Novai, Kam Pooni from Glyconics Ltd and David Browning from EarSwitch! The evening was packed with valuable insights, great discussions, and of course, amazing networking over drinks and nibbles. 🍷 Thank you to EY for hosting us and to everyone who attended for making it such a success! If you want to read about the key takeaways from the event then view the post written by our Head of Science and Entrepreneur Advocate, Philip Simister here: https://lnkd.in/eJaWGb8V #BioTuesday #DigitalMedTech #LifeSciences #ThankYou #Networking #Innovation #OBNEvents #MedTech

🚀 Calling all early-stage R&D companies! 🚀 Seeking seed funding? Don’t miss the chance to pitch at BioSeed London, the UK’s premier pitching event for early-stage life sciences companies, on 20 January 2025. 🎯 Pitch to c.100 active life sciences investors! 🎯 💥 Early Bird rates for R&D presentations ends next week! 💥 🔹 OBN Members: £400 + VAT (£500 + VAT after 1 Nov) 🔹 Non-Members: £500 + VAT (£600 + VAT after 1 Nov) What’s included? ✨ 5-minute live pitch ✨ Pre-event training & feedback ✨ Access to exclusive partnering meetings ✨ Full day attendance & post-event networking ✨ Extensive promotion via OBN channels Secure your slot 👉 https://lnkd.in/e3H-UJ5Y Active investors? Book your complimentary ticket here 👉 https://lnkd.in/e3H-UJ5Y #BioSeed #LifeSciences #SeedFunding #RDEntrepreneurs #OBN